Last update 01 Nov 2024
Nanjing Westcom Biotechnology Co Ltd

Nanjing Westcom Biotechnology Co Ltd

Private Company|
2011|
Jiangsu Sheng, China

Overview

Related

1
Drugs associated with Nanjing Westcom Biotechnology Co Ltd
Fosaprepitant Dimeglumine
Target
NK1R
Mechanism
NK1R antagonists
Active Org.
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. [+6]
Originator Org.
Merck & Co., Inc.Merck & Co., Inc.
Active Indication
Nausea [+2]
Inactive Indication
Germ Cell and Embryonal Neoplasms [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date11 Jan 2008
2
Clinical Trials associated with Nanjing Westcom Biotechnology Co Ltd
CTR20170465 / CompletedPhase 1
一项在中国健康志愿者中评价注射用福沙吡坦二甲葡胺单次给药的单中心、开放的药代动力学研究
[Translation] A single-center, open-label pharmacokinetic study evaluating a single-dose injection of fosaprepitant dimeglumine in healthy Chinese volunteers
CTR20170270 / CompletedPhase 3
一项评价注射用福沙吡坦二甲葡胺在预防高致吐性化疗所致的恶心、呕吐中的有效性及安全性研究
[Translation] A study to evaluate the efficacy and safety of fosaprepitant dimeglumine for injection in preventing nausea and vomiting caused by highly emetogenic chemotherapy
100 Clinical Results associated with Nanjing Westcom Biotechnology Co Ltd
Login to view more data
0 Patents (Medical) associated with Nanjing Westcom Biotechnology Co Ltd
Login to view more data
100 Deals associated with Nanjing Westcom Biotechnology Co Ltd
Login to view more data
100 Translational Medicine associated with Nanjing Westcom Biotechnology Co Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Fosaprepitant Dimeglumine
 ( NK1R )		Vomiting
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free